BioLife Solutions Inc (BLFS)

Financial leverage ratio

		Dec 31, 2023	Sep 30, 2023	Jun 30, 2023	Mar 31, 2023	Dec 31, 2022	Sep 30, 2022	Jun 30, 2022	Mar 31, 2022	Dec 31, 2021	Sep 30, 2021	Jun 30, 2021	Mar 31, 2021	Dec 31, 2020	Sep 30, 2020	Jun 30, 2020	Mar 31, 2020	Dec 31, 2019	Sep 30, 2019	Jun 30, 2019	Mar 31, 2019
Total assets	US$ in thousands	412,714	411,152	433,177	446,470	450,229	488,020	470,681	544,279	554,286	559,391	520,969	240,024	234,829	195,887	113,970	94,987	92,816	83,789	51,303	48,073
Total stockholders’ equity	US$ in thousands	337,663	332,017	352,128	358,107	364,188	405,120	409,544	476,075	478,047	489,259	452,281	208,777	204,429	186,851	105,843	67,709	43,321	35,191	2,072	-3,740
Financial leverage ratio		1.22	1.24	1.23	1.25	1.24	1.20	1.15	1.14	1.16	1.14	1.15	1.15	1.15	1.05	1.08	1.40	2.14	2.38	24.76	—

December 31, 2023 calculation

Financial leverage ratio = Total assets ÷ Total stockholders’ equity
= $412,714K ÷ $337,663K
= 1.22

The financial leverage ratio of BioLife Solutions Inc has fluctuated over the past few quarters, ranging from 1.05 to as high as 24.76. A financial leverage ratio greater than 1 indicates that the company relies more on debt financing than equity financing to support its operations and growth.

The notable spike to 24.76 in the financial leverage ratio as of March 31, 2020 raises concerns about the company's high level of debt relative to its equity. This could potentially indicate financial distress or a risky capital structure during that period.

Subsequent periods show a more normalized range of financial leverage ratios, although there are still fluctuations. It is essential for investors and stakeholders to closely monitor the financial leverage ratio to assess the company's capital structure stability and ascertain the effectiveness of its debt management strategies in the long run.